Dyadic to Participate in Bio-Manufacturing Innovation Summit and NIIMBL National Meeting

by B2i | Jul 5, 2022 | Press Releases

JUPITER, Fla., July 05, 2022 — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary and patented microbial technologies...

Dyadic to Participate in Three Upcoming Industry Events

by B2i | Jun 9, 2022 | Press Releases

JUPITER, Fla., June 09, 2022 — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1 protein production platform to...

Dyadic to Present at 2022 Jefferies Healthcare Conference

by B2i | Jun 2, 2022 | Press Releases

JUPITER, Fla., June 02, 2022 — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform...

Dyadic to Present at H.C. Wainwright Global Investment Conference

by B2i | May 20, 2022 | Press Releases

JUPITER, Fla., May 20, 2022 — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform...

Dyadic Reports First Quarter 2022 Financial Results and Highlights Recent Company Developments

by B2i | May 12, 2022 | Press Releases

New research, license, and collaboration agreement with a Global Food Ingredients Company using Dyadic’s proprietary biotechnologiesLicense agreement with Phibro/Abic Animal Health to develop and commercialize animal vaccine(s)Advancing first-in-human clinical...

Dyadic Announces Research, License and Collaboration for the Manufacture of Animal Free Ingredients

by B2i | May 11, 2022 | Press Releases

JUPITER, Fla., May 11, 2022 — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying, and...